XZP-3287 not checked

Xuanzhu Biopharmaceutical Co., Ltd.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
None yet
 
Trials
2 active
6 in total
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“XZP-3287 360 mg orally Twice daily(Q12H) of every 28-day cycle Fulvestrant 500mg intramuscular injection on day 1 and day 15 for the first cycle and then on day 1 for every cycle (28-day) until progressive disease”In the company’s words, NCT05077449 on ClinicalTrials.gov
Tested for
Advanced Breast Cancer (2 trials)
Main trialPhase 3
“This is a phase III clinical trial to evaluate the efficacy and safety of XZP-3287 in combination with Fulvestrant versus placebo combined with Fulvestrant in Patients who have HR positive and Her2 negative recurrent/metastatic breast cancer and have received prior endocrine therapy are eligible for study.”In the company’s words, NCT05077449 on ClinicalTrials.gov

Other drugs for Advanced Breast Cancer

All 397 drugs for Advanced Breast Cancer

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials6

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting 22 Feb 2024 A Study of XZP-3287 in Combination With Fulvestrant in Patients With Advanced Breast Cancer
Phase 3Active, not recruiting 5 Dec 2025 A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast Cancer
Phase 1/2Unknown 31 Jul 2023 A Phase I/II Study of XZP-3287 in Metastasis Solid Tumors
Phase 1Unknown Aug 2021 Effect of Food on the Pharmacokinetics of XZP-3287 in Healthy Subjects
Phase 1Unknown Sep 2021 Effect of Clarithromycin and Rifampicin on the Pharmacokinetics of XZP-3287 in Healthy Subjects
Phase 1Unknown 4 Jan 2023 A Clinical Trial of XZP-3287 for Material Balance
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow XZP-3287

Following is part of Solo: you see every change to XZP-3287 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in